Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian H de Boer

Showing results (1-10 of 403) with videos related to

Pageof 41
Sort By:
The New England Journal of Medicine|December 8, 2017
Liraglutide and Renal Outcomes in Type 2 DiabetesIan H de Boer
Clinical Journal of the American Society of Nephrology : CJASN|January 13, 2018
Nephrology at a CrossroadsIan H de Boer
Diabetes Care|December 21, 2013
Kidney disease and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications studyIan H de Boer,
The New England Journal of Medicine|August 31, 2017
A New Chapter for Diabetic Kidney DiseaseIan H de Boer
Current Opinion in Nephrology and Hypertension|October 23, 2008
Vitamin D and glucose metabolism in chronic kidney diseaseIan H de Boer
The Lancet. Diabetes & Endocrinology|June 15, 2019
The expanding résumé of SGLT2 inhibitorsIan H de Boer
JAMA|November 1, 2012
Chronic kidney disease—a challenge for all agesIan H de Boer
Clinical Journal of the American Society of Nephrology : CJASN|February 4, 2021
SGLT2 Inhibitors in Diabetic Kidney DiseaseSophia Zoungas, Ian H de Boer
Clinical Journal of the American Society of Nephrology : CJASN|October 19, 2013
Vitamin D deficiency: consequence or cause of CKD?Ian H de Boer, Ravi Thadhani
Kidney International|October 2, 2008
Vitamin D in chronic kidney disease: is the jury in?Ian H de Boer, Bryan Kestenbaum
Pageof 41

Showing results (1-10 of 403) with videos related to

Sort By:
Pageof 41
The New England Journal of Medicine|December 8, 2017
Liraglutide and Renal Outcomes in Type 2 DiabetesIan H de Boer
Clinical Journal of the American Society of Nephrology : CJASN|January 13, 2018
Nephrology at a CrossroadsIan H de Boer
Diabetes Care|December 21, 2013
Kidney disease and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications studyIan H de Boer,
The New England Journal of Medicine|August 31, 2017
A New Chapter for Diabetic Kidney DiseaseIan H de Boer
Current Opinion in Nephrology and Hypertension|October 23, 2008
Vitamin D and glucose metabolism in chronic kidney diseaseIan H de Boer
The Lancet. Diabetes & Endocrinology|June 15, 2019
The expanding résumé of SGLT2 inhibitorsIan H de Boer
JAMA|November 1, 2012
Chronic kidney disease—a challenge for all agesIan H de Boer
Clinical Journal of the American Society of Nephrology : CJASN|February 4, 2021
SGLT2 Inhibitors in Diabetic Kidney DiseaseSophia Zoungas, Ian H de Boer
Clinical Journal of the American Society of Nephrology : CJASN|October 19, 2013
Vitamin D deficiency: consequence or cause of CKD?Ian H de Boer, Ravi Thadhani
Kidney International|October 2, 2008
Vitamin D in chronic kidney disease: is the jury in?Ian H de Boer, Bryan Kestenbaum
Pageof 41